BRENTWOOD, Tenn. - Surgery Partners, Inc. (NASDAQ: NASDAQ:SGRY), a prominent operator of short-stay surgical facilities with ...
Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...
Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...
On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...
Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.
Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...
Brookfield has been given access to do due diligence for a potential acquisition of Insignia Financial after it presented a ...
Ltd. entered the bidding frenzy for Insignia Financial Ltd., joining Bain Capital and CC Capital Partners with an offer for ...
Bain Capital Specialty Finance, Inc. (NYSE: BCSF or the "Company") today announced that it has priced an offering of $350 million aggregate principal amount of 5.950% senior notes due 2030 (the "Notes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback